Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2010.062 | A multi-centre randomized, double-blind, controlled clinical trial to evaluate the effectiveness of the Transforming Relapse and Instilling Prosperity (TRIP) program as an Illness Management Program for in-patient with mental illness in Hong Kong | Mr Lee Chi Kwong |
| 2023.679 | A multi-centre prospective validation of an AI system to detect dysplasia/early cancer in Barrett's Oesophagus |
Dr. YIP Hon Chi 葉瀚智 |
| 2012.352 | A multi-centre long-term follow-up study to assess the durability of sustained virologic response in alisporivir-treated chronic Hepatitis C patients | Dr. HUI Aric Josun |
| 2005.244 | A Multi-Centre Clinical Study in Spinal Cord Injury Patients in Mainland China and Hong Kong | POON Wai Sang |
| 2012.350 | A multi-centre 3-year follow-up study to assess the viral activity in patients who failed to achieve sustained virologic response in Novartis-sponsored Alisporivir-studies for chronic Hepatitis C patients | Dr. HUI Aric Josun |
| 2013.264 | A multi-centre 3-year follow-up study to assess the viral activity in patients who failed to achieve sustained virologic response in Novartis-sponsored Alisporivir-studies for chronic Hepatitis C patients | Prof. Chan Lik Yuen Henry |
| 2013.156 | A multi-centre 3-year follow-up study to assess the durability of sustained virologic response in Alisporivir-treated chronic Hepatitis C patients | Prof. Chan Henry Lik-Yuen |
| 2018.234 | A multi-centered study: New technologies and plans for colorectal cancer screening |
Prof. SUNG Joseph Jao Yiu 沈祖堯 |
| 2015.317 | A multi-centered study on factors influencing the career interest in Obstetrics and Gynaecology of medical graduates in Hong Kong | Dr. HUI Annie |
| 2013.470 | A multi-center, uncontrolled extension study evaluating efficacy and safety of SAR153191 on top of DMARDs in patients with active Rheumatoid Arthritis (RA) | Prof Tam Lai Shan |
| 2008.383 | A Multi-Center, Randomized, Open-Label, Active-Controlled Study to Compare the Efficacy, Safety and Tolerability of Taspoglutide (RO5073031) versus Insulin Glargine in Insulin-Naive Type 2 Diabetic Patients Inadequately Controlled with Metformin and Sulphonylurea Combination Therapy | Prof. Kong Alice Pik-Shan |
| 2009.454 | A multi-center, randomized, open-label, active-controlled study to compare the efficacy, safety and tolerability of taspoglutide (RO5073031) versus insulin glargine in insulin-naive type 2 diabetic patients inadequately controlled with metformin and sulfonylurea combination therapy | Prof. Brian Tomlinson |
| 2021.709 | A Multi-center, Randomized, Double-Blinded, Parallel, Vildagliptin and Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of PB-201 in Treatment-naive Patients with Type 2 Diabetes Mellitus |
Prof. CHOW Elaine Yee Kwan 周怡君 |
| 2022.293 | A Multi-center, Randomized, Double-Blinded, Parallel and Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of PB-201 in Type 2 Diabetic Mellitus Patients with Poor Glycemic Control via Metformin Hydrochloride Monotherapy | Prof. CHOW Elaine Yee Kwan |
| 2010.147 | A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Determine the Efficacy, Safety, and Tolerability of AMG785 in Adults with Fresh Unilateral Intertrochanteric Fracture of the Proximal Femur, Status Post Fixation with a Sliding Hip Screw or Intramedullary Nail | Prof. Leung Kwok Sui |
| 2010.059 | A Multi-center, Randomized, Double-blind, Placebo-controlled Study of AMG 785 in Skeletally Mature Adults with a Fresh Unilateral Tibial Diaphyseal Fracture Status Post Definitive Fracture Fixation with an Intramedullary Nail | Professor Leung Kwok-Sui |
| 2009.426 | A multi-center, randomized, double-blind, placebo-controlled phase III trial comparing the efficacy of bevacizumab in combination with rituximab and CHOP (RA-CHOP) versus rituximab and CHOP (R-CHOP) in previously untreated patients with CD20-positive diffuse large B-cell lymphoma (DLBCL) | Dr. Lei Kenny Ieng Kit |
| 2009.489 | A multi-center, randomized, double-blind, placebo-controlled clinical trial of deferasirox in patients with myelodysplastic syndromes (low/int-1 risk) and tranfusional iron overload (TELESTO) | Dr. WONG Raymond Siu Ming |
| 2006.026 | A Multi-center, Randomized, Double-blind, Parallel Group, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Activated Recombinant Factor VII (rFVIIa/NovoSeven/NiaStase) in Severely Injured Trauma Patients With Bleeding Refractory to Standard Treatment | Prof. Timothy H. RAINER |
| 2007.228 | A Multi-center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared with Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Na_ve Patients with HBeAg Positive Chronic Hepatitis due to Hepatitis B Virus | Prof. Chan LY Henry |
| 2007.226 | A Multi-Center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared with Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Na_ve Patients with HBeAg Positive Chronic Hepatitis due to Hepatitis B Virus | Dr. Leung WY Nancy |
| 2007.229 | A Multi-center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared with Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Na_ve Patients with HBeAg Negative Chronic Hepatitis due to Hepatitis B Virus | Prof. Chan LY Henry |
| 2007.227 | A Multi-Center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared with Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Na_ve Patients with HBeAg Negative Chronic Hepatitis due to Hepatitis B Virus | Dr. Leung WY Nancy |
| 2012.408 | A Multi-Center, Prospective, Randomized Study Comparing Removable, Self-Expanding Metal Stents to Plastic Stents for the Treatment of Benign Biliary Strictures Secondary to Chronic Pancreatitis | Prof. LAU James Y.W. |
| 2008.135 | A Multi-center, Prospective, Randomised Controlled Trial Comparing the Efficacy and Safety of PRODISC-C_ Implant to Anterior Cervical Discectomy and Fusion (ACDF) Surgery, in the Treatment of Symptomatic Cervical Disc Disease (SCDD) | Prof. POON Wai Sang |
| 2016.616 | A multi-center, open-label, single arm, prospective study evaluating the sealing performance of the Shiley™ Laryngeal Mask in a post market clinical follow up (PMCF) |
Dr. CHAN Simon Kin Cheong 陳建昌 |
| 2015.238 | A multi-center, open -label study to assess the safety and efficacy of combination ceritinib (LDK378) and nivolumab in adult patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) |
Prof. MOK Tony Shu Kam 莫樹錦 |
| 2016.428 | A Multi-Center, International Registry to evaluate the treatment of Upper Tract Urothelial Cancer: Incidence, Indications, Treatment types and Outcomes. |
Dr. NG Chi Fai 吳志輝 |
| 2006.422 | A Multi-Center, Doubled-Blind, Randomized, Placebo-Controlled, Dose-Ranging Phase 2 Study to Investigate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of RO5073031 in Patients with Type 2 Diabetes Mellitus Treated with A Stable Dose of Metformin | Prof. Brian Tomlinson |
| 2006.421 | A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Phase 2 Study to Investigate Pharmacodynamics, Safety, Tolerability and Parmacokinetics of RO5073031 in Patients with Type 2 Diabetes Mellitus Treated with a Stable Dose of Metformin | Prof. Kong P.S. Alice |
| 2008.505 | A Multi-center, Double-blind, Randomized, Parallel Group, Placebo-controlled 12-week Study to Investigate Glycemic Parameters of Efficacy, Safety/Tolerability and Pharmacokinetics of Five Dose Levels of RO4998452 in Patients with Type 2 Diabetes Mellitus | Prof. Brian Tomlinson |
| 2008.515 | A Multi-center, Double-blind, Randomized, Parallel Group, Placebo-controlled 12-week Study to Investigate Glycemic Parameters of Efficacy, Safety/ Tolerability and Pharmacokinetics of Five Dose Levels of RO4998452 in Patients with Type 2 Diabetes Mellitus | Professor Kong Alice Pik-Shan |
| 2003.276 | A Multi-Center, Double-Blind, Randomized, Parallel Group Study to Evaluate the Effects of Two Different Doses of Losartan on Morbidity and Mortality in Patients with Symptomatic Heart Failure Intolerant of ACE Inhibitor Treatment | Prof. Yu Cheuk Man |
| 2006.258 | A Multi-Center, Double-Blind, Parallel-Group, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Denagliptin in Subjects with Type 2 Diabetes Mellitus | Prof. Kong Pik Shan Alice |
| 2006.312 | A Multi-Center, Double-Blind, Parallel-Group, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Denagliptin in Subjects with Type 2 Diabetes Mellitus | Prof. Ko Tin Choi Gary |
| 2015.406 | A multi-center, double blind, randomized, placebo controlled study of Testogel® (testosterone gel 50mg/5g) in the treatment of male hypogonadism | Prof. KONG Alice Pik Shan |
| 2008.391 | A Multi-Center, Continuation Trial of Belimumab (HGS1006, LymphoStat-B™), A Fully Human Monoclonal Anti-BLyS Antibody, in Subjects with Systemic Lupus Erythematosus (SLE) who Completed the Phase 3 Protocol HGS1006-C1056 or HGS1006-C1057 | Prof. TAM Lai Shan |
| 2008.077 | A Multi-center Study of Treatment Protocol for Childhood Acute Lymphoblastic Leukemia in China, 2008 | Dr Li Chi Kong |
| 2008.131 | A Multi-center Study of the Therapeutic Role of Continuous Positive Airway Pressure Therapy on Ischemic Stroke Survivors with Obstructive Sleep Apnoea Syndrome | Prof Hui David Shu-Cheong |
| 2015.188 | A multi-center retrospective study on parental decisions following prenatal diagnosis of sex chromosome aneuploidies in Hong Kong |
Prof. CHENG Yvonne Kwun Yue 鄭昆瑜 |
| 2016.585 | A Multi-Center Retrospective Observational Study to Evaluate PD-L1 Protein Expression in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) |
Prof. TO Ka Fai 杜家輝教授 |
| 2005.414 | A Multi-Center Prospective Randomized Phase III Trial to Determine the Benefit of Adjuvant Chemotherapy Using Gemcitabline and Cisplatin in Nasopharyngeal Carcinoma Patients with Residual EBV DNA Following Primary Radiotherapy with or without Concurrent Cisplatin | Prof. CHAN Anthony |
| 2005.245 | A Multi-center Prospective Randomized Phase III Trial to Determine the Benefit of Adjuvant Chemotherapy Using Gemcitabine and Cisplatin in Nasopharyngeal Carcinoma Patients with Residual EBV DNA Following Primary Radiotherapy With or Without Concurrent Cisplatin | Prof. Chan T.C. Anthony |
| 2006.338 | A Multi-Center Phase III Randomized, Double-Blind Placebo-Controlled Study of the Cancer Vaccine Stimuvax_ (L-BLP25 or BLP25 liposome vaccine) in Non-Small Cell Lung Cancer (NSCLC) Subjects with Unresectable Stage III Disease | Prof. Mok S.K. Tony |
| 2019.457 | A Multi-Center Expanded Access Program (EAP) for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors with Rearranged During Transfection (RET) Activation (LIBRETTO-201) |
Dr. LOONG Herbert Ho Fung 龍浩鋒 |
| 2006.372 | A Molecular Genetic Study of Psychiatric Morbidity in Stroke | Prof. TANG Wai Kwong |
| 2018.431 | A modified approach in estimating HIV undiagnosed interval for evaluating HIV epidemiology in Hong Kong |
Dr. WONG Ngai Sze 王艾斯 |
| 2022.584 | A mobile phone app-based intervention for supporting and empowering parents of children with autism spectrum disorder: a randomized waitlist-controlled trial |
Dr. WONG Oscar Wing Ho 黃永昊 |
| 2009.184 | A microRNA contribution to ezrin upregulation and Ras activation in gastric cancer | Dr. Jin Hongchuan |
| 2021.126 | A Microbiome-Based Noninvasive Diagnostic Test for Early Colorectal Cancers |
Dr. LIANG Jessie Qiaoyi 梁巧儀 |
Page 244 of 254.